e-learning
resources
Madrid 2019
Monday, 30.09.2019
Clinical problems from non-malignant pleural disease to hypoventilation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion
Y. Kogan (Haifa, Israel), E. Sabo (Haifa, Israel), M. Odeh (Haifa, Israel)
Source:
International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation
Session:
Clinical problems from non-malignant pleural disease to hypoventilation
Session type:
Poster Discussion
Number:
2027
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kogan (Haifa, Israel), E. Sabo (Haifa, Israel), M. Odeh (Haifa, Israel). Role of C-reactive protein in distinguishing between transudative and exudative pleural effusion. 2027
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Massive pleural effusion presented with a very rare multitude of complication
Related content which might interest you:
Rapid evaluation of exudative pleural effusion using C-reactive protein
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Diagnostic value of C-reactive protein in exudative pleural effusions
Source: International Congress 2019 – Clinical problems
Year: 2019
Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021
Diagnostic value of IL-8 in differentiating between exudative and transudative pleural effusion
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012
Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020
The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002
Effect of iatrogenic hemorrhage on biochemical parameters which are used to discriminate exudative and transudative pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 441s
Year: 2002
Diagnostic value of serum - effusion albumin gradient in distinguishing exudative and transudative effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 442s
Year: 2002
The implication of C-reactive protein in differentiation of various pleural effusion etiologies
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008
Comparison and relationship of cholesterol and lipoproteins of pleural effusions with serum levels of them in exudative and transudative pleural fluid
Source: Eur Respir J 2005; 26: Suppl. 49, 446s
Year: 2005
An exsudative pleural effusion
Source: Annual Congress 2010 - Thoracic Oncology Grand Round - an interactive session
Year: 2010
Angiopoietin-2 levels are elevated in exudative pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005
The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009
Evaluation of 276 patients with exudative pleural effusion
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept